Frontiers in Pharmacology (Jan 2025)
Corrigendum: Ginkgolide C alleviates myocardial ischemia/reperfusion-induced inflammatory injury via inhibition of CD40-NF-κB pathway
- Rui Zhang,
- Dan Han,
- Zhenyu Li,
- Chengwu Shen,
- Yahui Zhang,
- Jun Li,
- Genquan Yan,
- Shasha Li,
- Bo Hu,
- Jiangbing Li,
- Ping Liu
Affiliations
- Rui Zhang
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Dan Han
- Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
- Zhenyu Li
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Chengwu Shen
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Yahui Zhang
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Jun Li
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Genquan Yan
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Shasha Li
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Bo Hu
- Minimally Invasive Urology Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Jiangbing Li
- Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- Ping Liu
- Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
- DOI
- https://doi.org/10.3389/fphar.2024.1492520
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords
